These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 22448672)

  • 21. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis.
    D'Ambrosio R; Aghemo A; Rumi MG; Ronchi G; Donato MF; Paradis V; Colombo M; Bedossa P
    Hepatology; 2012 Aug; 56(2):532-43. PubMed ID: 22271347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.
    Wai CT; Greenson JK; Fontana RJ; Kalbfleisch JD; Marrero JA; Conjeevaram HS; Lok AS
    Hepatology; 2003 Aug; 38(2):518-26. PubMed ID: 12883497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression of initially mild hepatic fibrosis in patients with chronic hepatitis C infection.
    Williams MJ; Lang-Lenton M;
    J Viral Hepat; 2011 Jan; 18(1):17-22. PubMed ID: 20088889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis.
    Goodman ZD; Becker RL; Pockros PJ; Afdhal NH
    Hepatology; 2007 Apr; 45(4):886-94. PubMed ID: 17393526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
    Sulkowski MS; Mehta SH; Torbenson MS; Higgins Y; Brinkley SC; de Oca RM; Moore RD; Afdhal NH; Thomas DL
    AIDS; 2007 Oct; 21(16):2209-16. PubMed ID: 18090048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002.
    Schiavini M; Angeli E; Mainini A; Zerbi P; Duca PG; Gubertini G; Vago L; Fociani P; Giorgi R; Cargnel A
    HIV Med; 2006 Jul; 7(5):331-7. PubMed ID: 16945079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Histological characteristics of chronic hepatitis C in biopsy material].
    Jármay K; Karácsony G; Ozsvár Z; Nagy I; Schaff Z; Lonovics J
    Orv Hetil; 1998 Aug; 139(33):1955-60. PubMed ID: 9734212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression of fibrosis in chronic hepatitis C.
    Ghany MG; Kleiner DE; Alter H; Doo E; Khokar F; Promrat K; Herion D; Park Y; Liang TJ; Hoofnagle JH
    Gastroenterology; 2003 Jan; 124(1):97-104. PubMed ID: 12512034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of liver fibrosis among injection drug users with chronic hepatitis C.
    Wilson LE; Torbenson M; Astemborski J; Faruki H; Spoler C; Rai R; Mehta S; Kirk GD; Nelson K; Afdhal N; Thomas DL
    Hepatology; 2006 Apr; 43(4):788-95. PubMed ID: 16557548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
    Castéra L; Sebastiani G; Le Bail B; de Lédinghen V; Couzigou P; Alberti A
    J Hepatol; 2010 Feb; 52(2):191-8. PubMed ID: 20006397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation.
    Calvaruso V; Dhillon AP; Tsochatzis E; Manousou P; Grillo F; Germani G; Patch D; O'Beirne J; Burroughs AK
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1227-32. PubMed ID: 22432427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.
    Vădan R; Gheorghe L; Becheanu G; Iacob R; Iacob S; Gheorghe C
    Rom J Gastroenterol; 2003 Sep; 12(3):183-7. PubMed ID: 14502317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C.
    O'Brien MJ; Keating NM; Elderiny S; Cerda S; Keaveny AP; Afdhal NH; Nunes DP
    Am J Clin Pathol; 2000 Nov; 114(5):712-8. PubMed ID: 11068544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients.
    Lupşor M; Badea R; Stefănescu H; Grigorescu M; Sparchez Z; Serban A; Branda H; Iancu S; Maniu A
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):155-63. PubMed ID: 18568136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.
    Rafi H; Kabbaj N; Salihoun M; Amrani L; Acharki M; Guedira M; Nya M; Amrani N
    Arab J Gastroenterol; 2011 Sep; 12(3):136-8. PubMed ID: 22055591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
    J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
    Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
    Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Older age at the time of liver biopsy is the important risk factor for advanced fibrosis in patients with chronic hepatitis C.
    Svirtlih N; Jevtovic D; Simonovic J; Delic D; Dokic L; Gvozdenovic E; Boricic I; Nesic Z; Neskovic G; Urban V
    Hepatogastroenterology; 2007 Dec; 54(80):2324-7. PubMed ID: 18265657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.